The rating affirmation is based on several factors, including TRMC’s unrestricted liquidity and low leverage.
TRMC also faces challenges, including its location in a competitive service area and high reliance on governmental payers.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that TRMC will produce operating cash flow margins around 8 percent.
More articles on healthcare finance:
5 reactions to CMS’ new mandatory bundled payments for cardiac care
4 ways healthcare organizations can reduce claim denials
10 things to know about CMS’ new mandatory cardiac bundle
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
